SARS-CoV-2 and the newborn: what do we know? (Pt.2)
| 05 May 2022
Continuing our journey related to SARS-CoV-2 and the placenta, a very interesting contribution came from Facchetti et Al. who in 2020 reported their experience of mothers positive for the virus.
In detail, they analyzed a cohort of 15 women positive for the virus and whose placentas had undergone histopathological analysis from February 7 to May 15, 2020. Among these, the case of a young woman in whom transmission was reported was highlighted vertical (maternal-fetal) of SARS-CoV-2.
The authors, starting from the panorama that emerged in those months, reported that although viral placental infection had already been described in the literature, little was known about the potential vertical transmission of the virus.
Therefore, authors referred to a 29-year-old woman hospitalized at 37 weeks + 5 of the first pregnancy, due to fever (38.0°C) and idiopathic thrombocytopenia, diagnosed at the beginning of pregnancy.
Patient tested positive for SARS-CoV-2 RNA and X-ray imaging showed parenchymal pulmonary thickening. Because of the fever and worsening of thrombocytopenia, induced vaginal delivery was chosen, with support ventilation due to the onset of O2 saturation of 95% in room air. The male infant weighed 2840 kg and presented an APGAR score of 9/10.
Twenty-four hours after delivery the newborn had developed fever, difficulty breathing, vomiting, abdominal distension, hypotonia and mild skin rash. Chest X-ray revealed interstitial pneumonia and was transferred to intensive care, where mechanical ventilation was applied. After the birth test for SARS-CoV-2 the RNA on the nasopharyngeal swab was inconclusive, while it was positive 36 and 72 h after birth and at the age of 17 days. After giving birth, the mother recovered quickly, the fever subsided and the puerperal course proceeded normally.
The child was discharged on day 18 after birth in good general condition. Two months later delivery both mother and child were healthy and asymptomatic.
The patient's monoamniotic-monochorionic placenta weighed 448 gr (25-50th percentiles for age). No significant anomalies were found on umbilical cord insertion, umbilical cord vessels, fetal surface and membranes, while the dark brown chorionic parenchyma contained smaller light areas.
On microscopic examination, the chorionic plate both in the fetal and maternal area showed multiple foci (corresponding to about 40% of the total surface) with intervillous inflammatory infiltrate, composed of numerous monocytoid cells and mature macrophages and neutrophils.
In areas showing inflammation, villi showed variable variations consistent with fetal vascular malperfusion with avascular villi and stroma-vascular cariorressi. The dangerous deposition of fibrin was prominent in many areas.
In the remaining parenchyma, normal villi and focal chorangiosis was observed. No intra-villous inflammatory infiltrate (villite) was evident. Immunostain for SARS-CoV-2 proteins showed positivity in cytoplasm of the syncytiotrophoblast for both protein S and protein N (Fig. 1A and B). Protein N was also expressed by rare intervals macrophages and Hofbauer cells. In particular, while anti-nucleocapsid staining was homogeneously strong throughout the placental parenchyma, protein S immunoreactivity was variable and particularly strong in areas with abundant intervillous inflammation (Fig.1C).
SARS-CoV-2 proteins were not detected in the villi capillaries. Electron microcopy of formalin-fixed placental tissue revealed fine morphologic preservation. On negative stain EM (nsEM), they observed particles morphologically compatible with coronavirus. They consisted of round particles with an external “corona” made of peplomers, and their size ranged between 85 and 90 nm to 110x120 nm (including peplomers). Isolated coronavirus but also couples or small clusters of particles were identified (Fig. 2A).